| Code | 0903F | ||||||||||
| MA number | 29/0275/25-S | ||||||||||
| Product Form: | tbl flm 30x1x400 mg (blis.PVC/Al) - jednotk.bal. | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 06.09.2025 |
| Validity: | 06.09.2030 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_IBUSTAD_tbl flm_08_2025.pdf
|
| PIL: |
PIL_IBUSTAD_tbl flm_08_2025_OTC.pdf
|
| PIL: |
PIL_IBUSTAD_tbl flm_08_2025_Rx.pdf
|
| Dokument: |
VHS_IBUSTAD_SK_H_0327_001_002_DC_sumár.pdf
|
| Dokument: |
VHS_IBUSTAD_SK_H_0327_001-002_DC.pdf
|
| Safety feature | No |
| Data update: | 08.09.2025 |
